The device was not returned for analysis.A review of the lot history record did not identify any manufacturing nonconformities issued to the reported lot.Based on the information reviewed, the reported cerebrovascular accident and visual disturbances were due to procedural circumstances.The reported patient effect of stroke as listed in the mitraclip gen 4 system instructions for use, is a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the procedural stroke.Patient id: (b)(6).It was reported that on (b)(6) 2020 two mitraclips were implanted in the patient.The same day, the patient had diplopia and blurry vision in the setting of a punctate infarct in the left cerebellar hemisphere as found by a brain magnetic resonance imaging (mri).This was diagnosed as an ischemic stroke.The patient was treated with a heparin drip on (b)(6) 2020.The condition is ongoing.Subsequent to the previously filed report, additional information was received that the patient condition resolved on (b)(6) 2020, but the patient still had some symptoms such as arm, face, and leg weakness.The patient is able to move and perform daily activities independently.No additional information was provided.
|